1.16884
Fractogel® EMD DMAE (M)
weak anion exchanger, suspension in 20% ethanol and 150 mM NaCl (40-90 µm)
Synonym(s):
Fractogel® EMD DMAE (M)
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 mL | Estimated to ship TODAY | $103.00 | |
| 100 mL | Estimated to ship TODAY | $778.00 | |
| 500 mL | Estimated to ship onMay 06, 2026 | $2,730.00 | |
| 5 L | Estimated to ship TODAY | Inquire |
About This Item
$103.00
Estimated to ship TODAYDetails
Quality Level
ligand
diethylaminoethyl
product line
Fractogel®
form
resin
parameter
170 cm/hr flow rate, 8 bar max. pressure
matrix active group
methacrylate
mean particle size
40-90 μm
capacity
100 mg binding capacity (BSA/mg of resin)
transition temp
flash point 35 °C (calculated)
density
1.430 g/cm3
bulk density
1000 kg/m3
application(s)
gene therapy
recombinant protein
vaccine development
separation technique
weak anion exchange
storage temp.
2-30°C
General description
Features and Benefits
- Excellent binding to large viruses and plasmid DNA
- Homogenous binding with high selectivity and purity
- Lower elution volumes for the highest purity levels
- Compatibility with 2.5 % (v/v) aqueous benzyl alcohol containing 150 mM NaCl storage solution
Due to the titration behavior, the ion exchange capacity can be used from pH 2 to pH 9.5. The separation of proteins is based on reversible electrostatic interactions between the negatively charged regions of the proteins′ surface and the support. Proteins are retained efficiently on Fractogel® EMD DEAE when the pH of the buffer is about 1 unit above their isoelectric points (pl).
The strength of the binding depends on the following:
- the buffer system
- pH value of the buffer which determines the surface charge of the protein
- the degree of the ionization of the functional groups of the exchanger
- the concentration of the counter ions
- the charge density on the support (protein binding capacity)
Packaging
- 1.16884.0100: Fractogel® EMD DMAE (M) Resin 100ml
- 1.16884.0010: Fractogel® EMD DMAE (M) Resin 10ml
- 1.16884.0500: Fractogel® EMD DMAE (M) Resin 500ml
- 1.16884.5000: Fractogel® EMD DMAE (M) Resin 5L
Analysis Note
Microscopic evaluation: Uniform spherical particles,no agglomerates, no fines
Extractable matter (water): ≤ 0.03 %
Cerium: ≤ 1 µg/g
Pressure drop(column: ID=1.6 cm, L=10 cm at 5 ml/min): ≤ 1.0 bar
Particle size (d10): 37 - 45 µm
Particle size (d50): 48 - 60 µm
Particle size (d90): 63 - 77 µm
Colony forming units (TAMC + TYMC): ≤ 100 CFU/ml
Endotoxins: ≤ 1.00 EU/ml
Protein binding capacity (bovine serum albumin): 80 - 120 mg/ml
Functional test (b:a): ≤ 0.25
Functional test: Separation of conalbumin and human serum albumin
Legal Information
1 of 1
This Item | |||
|---|---|---|---|
| separation technique weak anion exchange | separation technique weak anion exchange | separation technique cation exchange, strong cation exchange | separation technique cation exchange, weak cation exchange |
| ligand diethylaminoethyl | ligand diethylaminoethyl | ligand (Sulfoisobutyl) | ligand carboxymethyl |
| form resin | form resin | form resin | form resin |
| capacity 100 mg binding capacity (BSA/mg of resin) | capacity 100 mg binding capacity (BSA/mg of resin) | capacity 130 mg binding capacity (lysozyme/ml of resin) | capacity 100 mg binding capacity (lysozyme/ml of resin) |
| matrix active group methacrylate | matrix active group methacrylate | matrix active group methacrylate | matrix active group methacrylate |
| product line Fractogel® | product line Fractogel® | product line Fractogel® | product line Fractogel® |
Still not finding the right product?
Explore all of our products under Fractogel® EMD DMAE (M)
signalword
Warning
hcodes
Hazard Classifications
Flam. Liq. 3
Storage Class
3 - Flammable liquids
wgk
WGK 3
flash_point_f
95.0 °F
flash_point_c
35 °C
Stay compliant with GMP using the Emprove® Program
Accelerate qualification, maintain compliance, and save time with Emprove® Dossiers.
Note: you will be brought to EmproveSuite.com. Your username and password are separate from SigmaAldrich.com and may differ.
Register for free and access Emprove® Dossiers within minutes. Upgrade your subscription plan to unlock advanced and customized content in the Emprove® Suite
Not finding what you are looking for? Visit the Emprove® Program Help page.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.
See case study examples of how to optimize chromatographic purification of plasmid DNA for Biopharmaceutical Applications.
Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.
Related Content
La fabricación de vacunas víricas a medida aborda los retos específicos del virus mediante la colaboración.
This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 1168840100 | 04022536741956 |
| 1168849999 | 04022536718125 |
| 1168845000 | 04022536168746 |
| 1168840010 | 04022536595252 |
| 1168840500 | 04022536168739 |